Cargando…

Noninvasive determinants of pulmonary hypertension in interstitial lung disease

Pulmonary hypertension (PH) in interstitial lung disease (ILD) is associated with increased mortality and impaired exertional capacity. Right heart catheterization is the diagnostic standard for PH but is invasive and not readily available. Noninvasive physiologic evaluation may predict PH in ILD. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Phillip, Savarimuthu, Stella, Zhao, Jiayi, Yan, Xiting, Oakland, Hannah T., Cullinan, Marjorie, Heerdt, Paul M., Singh, Inderjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939578/
https://www.ncbi.nlm.nih.gov/pubmed/36814586
http://dx.doi.org/10.1002/pul2.12197
_version_ 1784890885438177280
author Joseph, Phillip
Savarimuthu, Stella
Zhao, Jiayi
Yan, Xiting
Oakland, Hannah T.
Cullinan, Marjorie
Heerdt, Paul M.
Singh, Inderjit
author_facet Joseph, Phillip
Savarimuthu, Stella
Zhao, Jiayi
Yan, Xiting
Oakland, Hannah T.
Cullinan, Marjorie
Heerdt, Paul M.
Singh, Inderjit
author_sort Joseph, Phillip
collection PubMed
description Pulmonary hypertension (PH) in interstitial lung disease (ILD) is associated with increased mortality and impaired exertional capacity. Right heart catheterization is the diagnostic standard for PH but is invasive and not readily available. Noninvasive physiologic evaluation may predict PH in ILD. Forty‐four patients with PH and ILD (PH‐ILD) were compared with 22 with ILD alone (non‐PH ILD). Six‐min walk distance (6MWD, 223 ± 131 vs. 331 ± 125 m, p = 0.02) and diffusing capacity for carbon monoxide (DLCO, 33 ± 14% vs. 55 ± 21%, p < 0.001) were lower in patients with PH‐ILD. PH‐ILD patients exhibited a lower gas‐exchange derived pulmonary vascular capacitance (GX(CAP), 251 ± 132 vs. 465 ± 282 mL × mmHg, p < 0.0001) and extrapolated maximum oxygen uptake (VO(2max)) (56 ± 32% vs. 84 ± 37%, p = 0.003). Multivariate analysis was performed to determine predictors of VO(2) (max). GX(CAP) was the only variable that predicted extrapolated VO(2) (max) among PH‐ILD and non‐PH ILD patients. Receiver operating characteristic curve analysis assessed the ability of individual noninvasive variables to distinguish between PH‐ILD and non‐PH ILD patients. GX(CAP) (area under the curve [AUC] 0.85 ± 0.04, p < 0.0001) and delta ETCO(2) (AUC 0.84 ± 0.04, p < 0.0001) were the strongest predictors of PH‐ILD. A CART analysis selected GX(CAP), estimated right ventricular systolic pressure (eRVSP) by echocardiogram, and FVC/DLCO ratio as predictive variables for PH‐ILD. With this analysis, the AUC improved to 0.94 (sensitivity of 0.86 and sensitivity of 0.93). Patients with a GX(CAP) ≤ 416 mL × mmHg had an 82% probability of PH‐ILD. Patients with GX(CAP) ≤ 416 mL × mmHg and high FVC/DLCO ratio >1.7 had an 80% probability of PH‐ILD. Patients with GX(CAP) ≤ 416 mL × mmHg and an elevated eRVSP by echocardiogram >43 mmHg had 100% probability of PH‐ILD. The incorporation of GX(CAP) with either eRVSP or FVC/DLCO ratio distinguishes between PH‐ILD and non‐PH‐ILD with high probability and may therefore assist in determining the need to proceed with a diagnostic right heart catheterization and potential initiation of pulmonary arterial hypertension‐directed therapy in PH‐ILD patients.
format Online
Article
Text
id pubmed-9939578
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99395782023-02-21 Noninvasive determinants of pulmonary hypertension in interstitial lung disease Joseph, Phillip Savarimuthu, Stella Zhao, Jiayi Yan, Xiting Oakland, Hannah T. Cullinan, Marjorie Heerdt, Paul M. Singh, Inderjit Pulm Circ Research Articles Pulmonary hypertension (PH) in interstitial lung disease (ILD) is associated with increased mortality and impaired exertional capacity. Right heart catheterization is the diagnostic standard for PH but is invasive and not readily available. Noninvasive physiologic evaluation may predict PH in ILD. Forty‐four patients with PH and ILD (PH‐ILD) were compared with 22 with ILD alone (non‐PH ILD). Six‐min walk distance (6MWD, 223 ± 131 vs. 331 ± 125 m, p = 0.02) and diffusing capacity for carbon monoxide (DLCO, 33 ± 14% vs. 55 ± 21%, p < 0.001) were lower in patients with PH‐ILD. PH‐ILD patients exhibited a lower gas‐exchange derived pulmonary vascular capacitance (GX(CAP), 251 ± 132 vs. 465 ± 282 mL × mmHg, p < 0.0001) and extrapolated maximum oxygen uptake (VO(2max)) (56 ± 32% vs. 84 ± 37%, p = 0.003). Multivariate analysis was performed to determine predictors of VO(2) (max). GX(CAP) was the only variable that predicted extrapolated VO(2) (max) among PH‐ILD and non‐PH ILD patients. Receiver operating characteristic curve analysis assessed the ability of individual noninvasive variables to distinguish between PH‐ILD and non‐PH ILD patients. GX(CAP) (area under the curve [AUC] 0.85 ± 0.04, p < 0.0001) and delta ETCO(2) (AUC 0.84 ± 0.04, p < 0.0001) were the strongest predictors of PH‐ILD. A CART analysis selected GX(CAP), estimated right ventricular systolic pressure (eRVSP) by echocardiogram, and FVC/DLCO ratio as predictive variables for PH‐ILD. With this analysis, the AUC improved to 0.94 (sensitivity of 0.86 and sensitivity of 0.93). Patients with a GX(CAP) ≤ 416 mL × mmHg had an 82% probability of PH‐ILD. Patients with GX(CAP) ≤ 416 mL × mmHg and high FVC/DLCO ratio >1.7 had an 80% probability of PH‐ILD. Patients with GX(CAP) ≤ 416 mL × mmHg and an elevated eRVSP by echocardiogram >43 mmHg had 100% probability of PH‐ILD. The incorporation of GX(CAP) with either eRVSP or FVC/DLCO ratio distinguishes between PH‐ILD and non‐PH‐ILD with high probability and may therefore assist in determining the need to proceed with a diagnostic right heart catheterization and potential initiation of pulmonary arterial hypertension‐directed therapy in PH‐ILD patients. John Wiley and Sons Inc. 2023-02-19 /pmc/articles/PMC9939578/ /pubmed/36814586 http://dx.doi.org/10.1002/pul2.12197 Text en © 2023 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Joseph, Phillip
Savarimuthu, Stella
Zhao, Jiayi
Yan, Xiting
Oakland, Hannah T.
Cullinan, Marjorie
Heerdt, Paul M.
Singh, Inderjit
Noninvasive determinants of pulmonary hypertension in interstitial lung disease
title Noninvasive determinants of pulmonary hypertension in interstitial lung disease
title_full Noninvasive determinants of pulmonary hypertension in interstitial lung disease
title_fullStr Noninvasive determinants of pulmonary hypertension in interstitial lung disease
title_full_unstemmed Noninvasive determinants of pulmonary hypertension in interstitial lung disease
title_short Noninvasive determinants of pulmonary hypertension in interstitial lung disease
title_sort noninvasive determinants of pulmonary hypertension in interstitial lung disease
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939578/
https://www.ncbi.nlm.nih.gov/pubmed/36814586
http://dx.doi.org/10.1002/pul2.12197
work_keys_str_mv AT josephphillip noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT savarimuthustella noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT zhaojiayi noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT yanxiting noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT oaklandhannaht noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT cullinanmarjorie noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT heerdtpaulm noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease
AT singhinderjit noninvasivedeterminantsofpulmonaryhypertensionininterstitiallungdisease